Diabetes Technology Meeting

Meeting Agenda (All Times Pacific)Register Now

Tuesday, October 15, 2024

6:45     BREAKFAST

Workshop A, Session 1: Data Science and Artificial Intelligence

8:15     Rising T1DE Alliance and D-Data Dock: Transforming Care via Integration of CGM and Other Clinical Data
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospital, Kansas City, Missouri, USA

8:30     AI Technologies in Enhancing Treatment of Diabetes
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

8:45     Digital Twins in T1D Therapy: Practical Applications and Benefits
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy

9:00     AI-enabled Dual-Hormone Pramlintide and Insulin MPC Control Algorithm and In-Silico Results
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

9:15     Integrating AI and Machine Learning for Prediabetes: Predictive Models and Intervention Strategies for Early Diagnosis and Management
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, MD

9:30     Q&A

9:45    BREAK

Workshop A, session 2: Real World Evidence for Diabetes Trials

10:15 Aviation Medicine for People with Diabetes
Renald Meçani

10:30   Real World Evidence Applied to Clinical Care
Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria

10:45   Harnessing University of California Health Data Warehouse to Learn Effective and Safe Treatments in Type 2 Diabetes
Rohit Vashisht, PhD
University of California, San Francisco, San Francisco, California, USA

11:00   How Diabetes Research Hub (DRH) Modernizes and Enhances RWE Utilization
Shahid N. Shah, M.Sc.
Netspective Communications, Silver Spring, Maryland, USA

11:15   Panel Discussion

11:45   LUNCH

Workshop B, Session 1: New Diagnostic Tests  

13:15   Current Research Programs at Breakthrough T1D
Aaron Kowalski, PhD
Breakthrough T1D, New York City, New York, USA

13:30   Antibodies to Diagnose Diabetes
Zoe Quandt, MD
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, California, USA

13:45   Continuous Insulin Monitoring
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA

14:00   Cardiac Blood Pressure and Exercise Monitoring
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA

14:15   Qualitative Hypoglycemia Detection
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA

14:30   Q&A

14:40   BREAK

Workshop B, Session 2: Drugs, Insulin and Technology 

15:10   Storage of Insulin
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany

15:25   Use of GLP-1 RAs Before Surgery
Sun H. Kim, MD
Department of Medicine – Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California, USA

15:40   Solutions for Age-Related and Drug-Induced Muscle Loss: A Major Public Health Problem
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA

15:55   Vertex Type 1 Diabetes Clinical Trials
Jean-Marc Guettier, MD
Vertex Pharmaceuticals, Boston, MA, USA

16:10   Insulin Pump Therapy in the Hospital
Robert J. Rushakoff, MD
University of California, San Francisco, San Francisco, CA, USA

16:25   Q&A

16:30  Poster Session

 

Wednesday, October 16, 2024

6:30     BREAKFAST

8:00     Welcome and Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05     Keynote Presentation - How is the FDA OIVD evolving to regulate new technologies?
Anthony Maiorana, PhD
Diabetes Branch, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Session 1: HOW BIG TECH SEES DIABETES 

8:30     Panelists

Erich Huang, MD, PhD
Verily, South San Francisco, California, USA

Alyssa Patel, PharmD, BCACP
Clinical Pharmacist, Chronic Care, One Medical, San Francisco, California, USA

Aiman Abdel-Malek, PhD
Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA

Praveen Raja, PhD
Samsung Research America

8:35     Panel Discussion

9:40     BREAK

Session 2: New Uses of CGMs

10:10   Nutrition Monitoring for Diabetes
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA

10:25   Use of CGMs by Elite Athletes
Howard Zisser, MD
University of California Santa Barbara, Santa Barbara, CA, USA

10:40   CGM for Prediabetes
Michael P. Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, California, USA

10:55   Q&A

Session 3: Who Can Sell Your Data 

11:05   An Oceania Perspective
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand

11:20   An FTC Regulatory Perspective
Jamie E. Darch, JD
Ropes & Gray LLP, Chicago, Illinois, USA

11:35   A United States Perspective
Bonnie Odom, JD, MPH
Epstein Becker & Green, P.C., San Diego, California, USA

11:50   Q&A

12:00   LUNCH

Session 4: Payers/Economics for Digital Health Interventions

13:30   Panelists

Amanda Adler, MD, PhD, FRCP
Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, United Kingdom

Jessie Juusola, PhD
Anchor Outcomes, San Francisco, CA, USA

Jordan Silberman, MD, PhD
Elevance Health, Palo Alto, CA, USA

Paul Radensky, MD, JD
McDermott Will & Emery/McDermott+, Washington, DC, USA

13:35   Panel Discussion

Session 5: Analyzing Data from a CGM

14:30   Time in Tight Range
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, Florida, USA

14:42   Diagnostic CGM: Analytics allowing CGM-based differentiation of diabetes stages and treatments
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

14:54   Glycemia Risk Index
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA

15:06   Interpreting CGM Data with the Glycemia Risk Index
Ralph Oiknine, MD
Diabetes & Endocrinology Specialists Inc, Chesterfield, Missouri, USA

15:18   Q&A

15:30   BREAK

Session 6: How to Improve Artificial Pancreas Performance

16:00   Incorporating Exercise into Closed Loop Algorithms
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

16:12   Female Fertility and AID performance: Menses and Pregnancy
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

16:24   Bihormonal Closed Loop Control
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA

16:36   The Use of GLP-1RAs with AIDs
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA

16:48   Q&A

17:00   Poster Session

 

Thursday, October 17, 2024

6:30     BREAKFAST

Session 7: HOW Tech can Improve Adherence to Diabetes Rx

8:00     TBD
TBD

8:12     Using Behavioural Science and Design Thinking to Develop more Engaging Digital Diabetes Innovations
Paula Voorheis, PhD
Science of Care Institute, Sinai Health System, Toronto, ON, CAN

8:24     Three key technologies that improve adherence among diabetes patients within the Los Angeles General Medical Center, the largest medical center in the Los Angeles County Health Care System
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA

8:36     How Technology Enhances Patient Engagement
William Polonsky, PhD
Behavioral Diabetes Institute & University of California, San Diego, San Diego, California, USA

8:48     Q&A

Session 8: Accuracy of Diabetes Devices

9:00     The New DTS Error Grid and Trend Accuracy Matrix
Michael Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA

9:15     Reliability and Comparability of CGM Performance Endpoints
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany

9:30     Limitations of Using the MARD for Accuracy
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, MA

9:45     Q&A

9:55     BREAK

Session 9: Innovation Challenge

10:25   Open DCB Innovation Challenge
Diabetes Center Berne, Berne, Switzerland

11:30   LUNCH

Session 10: Physiology of Inserted and Implanted Devices (non-accredited)

1:00     The Science of Extended Wear Infusion Sets
Rayhan Lal, MD
Stanford University, Palo Alto, CA, USA

13:12   Update on Optical Glucose Measurement
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA

13:24   The DERMIS Study: What Does Insulin Pump Therapy do to the Skin, and Where Do We Go From Here?
Irl B. Hirsch, MD
University of Washington, Seattle, Washington, USA

13:36   The Technology Behind Continuous Blood Glucose Monitoring
Mark Tapsak, PhD
Glucotrack, Rutherford, New Jersey, USA

13:48   Q&A

Session 11: NEW developments in cgm products (non-accredited)

14:00   Update from Abbott
Marc Taub, PhD
Abbott Diabetes Care, Chicago, Illinois, USA

14:10   Update from Dexcom
Jessica Castle, MD
Dexcom, Inc, San Diego, California, USA

14:20   Update from Medtronic
Lou Lintereur, MS
Medtronic Diabetes, Los Angeles, CA, USA

14:30   Update from Roche
Timor Glatzer, PhD
Roche Diabetes Care, Inc, Indianapolis, Indiana, USA

14:40   Update from Senseonics
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA

14:50   Q&A

15:00   BREAK

Session 12: Hot  Topics

15:30   ChatGPT Applied to Diabetes
Sultan A. Meo, MBBS, Ph.D, MMed Ed, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia

15:45   Green Diabetes Project
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany

16:00   Use of CGMs in People without Diabetes
Tracey  McLaughlin, MD, MPH
Stanford School of Medicine

16:15   Continuous Glucose Monitoring (CGM)-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naïve Individuals with Type 2 Diabetes (ONWARDS 9)
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, MN, USA

Session 13: Live Demonstration 

16:35   OneStep Foot Scanner
Chris Sandroussi
Bluedrop Medical